NL2030973B1 - Primer set for detection of expression of human eosinophil cationic protein (ecp) mrna and kit - Google Patents
Primer set for detection of expression of human eosinophil cationic protein (ecp) mrna and kit Download PDFInfo
- Publication number
- NL2030973B1 NL2030973B1 NL2030973A NL2030973A NL2030973B1 NL 2030973 B1 NL2030973 B1 NL 2030973B1 NL 2030973 A NL2030973 A NL 2030973A NL 2030973 A NL2030973 A NL 2030973A NL 2030973 B1 NL2030973 B1 NL 2030973B1
- Authority
- NL
- Netherlands
- Prior art keywords
- ecp
- probe
- mrna
- kit
- seq
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Claims (8)
1. Primerset voor detectie van een expressie van een humaan eo- sinofiel kationisch eiwit (ECP) mRNA, omvattende een ECP-F, een ECP-R, een GAPDH-F en een GAPDH-R; waarbij de ECP-F een nucleotideseduentie heeft die wordt getoond in SEQ ID
NO. 1, de ECP-R een nucleotidesequentie heeftdie wordt getoond in SEQ ID NO. 2, de GAPDH-F een nucleotidesequentie heeft die wordt getoond in SEQ ID NO. 3, en de GAPDH-R een nucleotidesequentie heeft die wordt getoond in SEQ ID NO. 4.
2. Primerset volgens conclusie 1, verder omvattende een probe E- Probe en een probe G-Probe; waarbij de E-Probe een nucleotideseguentie heeft die wordt getoond in SEQ ID NO. 5, en de G-Probe een nucleotidesequentie heeft die wordt getoond in SEQ ID NO. 6.
3. Primerset volgens conclusie 2, waarbij 5'-uiteinden van de pro- be E-Probe en de probe G-Probe beide zijn verbonden met een fluo- rescerende groep, en 3'-uiteinden van de probe E-Probe en de probe G-Probe beide zijn verbonden met een guenchgroep.
4. Primerset volgens conclusie 2 of 3, waarbij de 5'-uiteinden van de probes E-Probe en G-Probe zijn verbonden met verschillende flu- orescerende groepen, en de 3'-uiteinden van de probes E-Probe en G-Probe zijn verbonden met een zelfde quenchgroep.
5. Kit voor detectie in één stap van een expressie van een humaan ECP-mRNA, omvattende de primerset volgens een van de conclusies 1-
4.
6. Kit volgens conclusie 5, verder omvattende een PCR- reactieoplossing, een gemengde enzymoplossing, een carboxy-X- rhodamine (ROX) referentiekleurstof en nucleasevrij water; waarbij een enzym in de gemengde enzymoplossing een thermus aquaticus (Taq) enzym, een reverse transcriptase, een ribonuclease (RNase)-
remmer en een Tag-enzym antilichaam omvat met een massaverhouding van 13:5:3:1.
7. Kit volgens conclusie 6, waarbij de PCR-reactieoplossing een mengsel van deoxy-ribonucleosidetrifosfaat (dNTP) mengsel, MgCl. en een buffer omvat.
8. Kit volgens conclusie 5 of 6, verder omvattende een standaard van het humane ECP-mRNA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110891409.7A CN113373218A (zh) | 2021-08-04 | 2021-08-04 | 一组检测人嗜酸性粒细胞阳离子蛋白mRNA表达的引物组和试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
NL2030973A NL2030973A (en) | 2023-02-15 |
NL2030973B1 true NL2030973B1 (en) | 2023-02-24 |
Family
ID=77576817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL2030973A NL2030973B1 (en) | 2021-08-04 | 2022-02-16 | Primer set for detection of expression of human eosinophil cationic protein (ecp) mrna and kit |
Country Status (4)
Country | Link |
---|---|
CN (1) | CN113373218A (nl) |
AU (1) | AU2021106592A4 (nl) |
NL (1) | NL2030973B1 (nl) |
ZA (1) | ZA202200493B (nl) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023010325A1 (zh) * | 2021-08-04 | 2023-02-09 | 杭州浙大迪迅生物基因工程有限公司 | 一组检测人嗜酸性粒细胞阳离子蛋白mRNA表达的引物组、试剂盒和检测方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0111194D0 (en) * | 2001-05-08 | 2001-06-27 | Innoventus Uppsala Life Scienc | Sequences |
EP1549676A1 (en) * | 2002-09-30 | 2005-07-06 | Oncotherapy Science, Inc. | Genes and polypeptides relating to human myeloid leukemia |
US20160208246A1 (en) * | 2013-06-10 | 2016-07-21 | Yeda Research And Development Co. Ltd. | Compositions and methods for treating a hematological malignancy associated with an altered runx1 activity or expression |
GB201521357D0 (en) * | 2015-12-03 | 2016-01-20 | Univ Liverpool | Methods for predicting response to anti-TNF therapy |
WO2017125402A1 (en) * | 2016-01-19 | 2017-07-27 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods of predicting drug responsiveness of patients suffering from autoimmune inflammatory diseases |
WO2018178993A1 (en) * | 2017-03-30 | 2018-10-04 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Diagnostic methods and kits for early detection of ovarian cancer |
CN108220483A (zh) * | 2018-02-12 | 2018-06-29 | 深圳出入境检验检疫局动植物检验检疫技术中心 | 一种用于罗非鱼湖病毒检测的试剂、检测方法及应用 |
WO2020190682A1 (en) * | 2019-03-15 | 2020-09-24 | Research Institute At Nationwide Children's Hospital | Compositions and methods for diagnosing acute infectious peritonitis |
CN110643740B (zh) * | 2019-10-15 | 2023-08-04 | 云南省畜牧兽医科学院 | 帕利亚姆血清群病毒的实时荧光定量rt-pcr检测引物、探针及检测试剂盒 |
CN111304368A (zh) * | 2020-03-19 | 2020-06-19 | 艾康生物技术(杭州)有限公司 | 用于检测新型冠状病毒的方法、寡核苷酸和试剂盒 |
CN111500773B (zh) * | 2020-04-28 | 2023-09-29 | 云南省畜牧兽医科学院 | 一种流行性出血病病毒血清型鉴定荧光定量rt-pcr引物、探针和试剂盒 |
-
2021
- 2021-08-04 CN CN202110891409.7A patent/CN113373218A/zh active Pending
- 2021-08-23 AU AU2021106592A patent/AU2021106592A4/en active Active
-
2022
- 2022-01-11 ZA ZA2022/00493A patent/ZA202200493B/en unknown
- 2022-02-16 NL NL2030973A patent/NL2030973B1/en active
Also Published As
Publication number | Publication date |
---|---|
CN113373218A (zh) | 2021-09-10 |
AU2021106592A4 (en) | 2021-11-11 |
NL2030973A (en) | 2023-02-15 |
ZA202200493B (en) | 2022-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4023767A1 (en) | Method, composition and kit for fluorescent quantitative pcr, and use thereof | |
US20200123606A1 (en) | Rt-qpcr method for direct quantitative detection of circulating mirna | |
NL2030973B1 (en) | Primer set for detection of expression of human eosinophil cationic protein (ecp) mrna and kit | |
CN111521781B (zh) | 一种用于新冠肺炎病毒SARS-CoV-2核酸的检测试剂盒及其检测方法 | |
WO2023010326A1 (zh) | 一种人β-类胰蛋白酶mRNA RT-PCR检测用引物探针组和试剂盒 | |
CN113046452B (zh) | 一种用于检测类鼻疽伯克霍尔德菌的组合物及其应用 | |
NL2030975B1 (en) | Primer probe set and kit for rt-pcr detection of human leukotriene receptor cysltr2 mrna | |
AU2021106586A4 (en) | Reagent for detecting expression level of human histamine receptor hrh4 mrna, kit and use | |
Gallup et al. | New quick method for isolating RNA from laser captured cells stained by immunofluorescent immunohistochemistry; RNA suitable for direct use in fluorogenic TaqMan one-step real-time RT-PCR | |
EP4289968A1 (en) | Primer-probe set and kit for human leukotriene receptor cysltr1 mrna rt-pcr detection | |
CN112553378B (zh) | 检测2019-nCoV的试剂、试剂盒及应用 | |
US20240150832A1 (en) | Reagent for detecting expression level of human histamine receptor hrh4 mrna, kit and detection method | |
WO2023010325A1 (zh) | 一组检测人嗜酸性粒细胞阳离子蛋白mRNA表达的引物组、试剂盒和检测方法 | |
NL2030974B1 (en) | Primer probe set and kit for rt-pcr detection of human tryptase beta (tpsb) mrna | |
CN103789447A (zh) | 一种5’端tRNA半分子检测方法 | |
NL2030976B1 (en) | Primer probe set and kit for rt-pcr detection of human leukotriene receptor cysltr1 mrna | |
CN108192890A (zh) | 一种改进的反转录microRNA的方法 | |
NL2030978B1 (en) | Primer probe set for human histamine receptor hrh1 mrna detection, kit and use | |
CN108165667A (zh) | 人呼吸道合胞病毒三重实时荧光定量rt-pcr检测试剂盒 | |
CN116949142B (zh) | 一种用于rna靶标检测的扩增方法及试剂盒应用 | |
CN112226528B (zh) | 一种用于生物组织样本检测细菌污染的质检方法 | |
CN116426668B (zh) | 一种基于核酸质谱技术检测毛霉菌的引物组及其应用 | |
WO2023010327A1 (zh) | 一种人白三烯受体CysLTR2 mRNA RT-PCR检测用引物探针组和试剂盒 | |
CN115725702A (zh) | 一种人内源性rna内标的荧光rt-pcr引物和探针、试剂盒及使用方法 | |
CN117265187A (zh) | 鉴别新型冠状病毒Omicron株BA.4亚系的引物和探针组合物、试剂盒和应用 |